ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Adalimumab and psoriatic arthritis"

  • Abstract Number: 2970 • 2017 ACR/ARHP Annual Meeting

    Inhibition of Radiographic Progression in Psoriatic Arthritis By Adalimumab Independent of the Control of Clinical Disease Activity

    Robert B.M. Landewé1, Christopher T. Ritchlin2, Laura C Coates3, Daniel Aletaha4, Benoît Guérette5, Ying Zhang5, Fabiana Ganz6 and Maja Hojnik7, 1University of Amsterdam, Amsterdam, Netherlands, 2Division of Allergy, Immunology and Rheumatology, School of Medicine and Dentistry, Division of Allergy, Immunology and Rheumatology, School of Medicine and Dentistry, University of Rochester, Rochester, New York, USA, Rochester, NY, 3University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, Great Britain, 4Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 5AbbVie Inc., North Chicago, IL, 6AbbVie AG, Baar, Switzerland, 7AbbVie, Ljubljana, Slovenia

    Background/Purpose : Patients (pts) with psoriatic arthritis (PsA) may experience structural damage and irreversible functional impairment if not treated appropriately. Treatment with TNF inhibitors in…
  • Abstract Number: 2894 • 2015 ACR/ARHP Annual Meeting

    The Majority of Patients with Moderate to Severe Psoriatic Arthritis Had Existing Structural Damage, Predisposing Them to Further Progression, Which Was Markedly Inhibited By Adalimumab

    Pranav Sheth1, Philip J. Mease2, Yihan Li3, Fabiana Ganz4 and Maja Hojnik5, 1Group Health Associates, Trihealth, Cincinnati, OH, 2Seattle Rheumatology Associates, Seattle, WA, 3AbbVie Inc., North Chicago, IL, 4Neuhofstrasse 23, AbbVie AG, Baar, Switzerland, 5AbbVie, Ljubljana, Slovenia

    Background/Purpose: Patients (pts) with psoriatic arthritis (PsA) may experience structural damage if not appropriately treated. The purpose was to determine 1) the frequency of radiographic…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.